Are you Dr. Shibata?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Los Angeles, CA 90089Phone+1 323-442-2582Fax+1 323-442-2588
Summary
- Dr. Darryl Shibata, MD is a board certified pathologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with USC Norris Comprehensive Cancer Center, Keck Hospital of USC, and Los Angeles Community Hospital at Los Angeles.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 1984 - 1989
University of California (San Diego) Medical CenterInternship, Transitional Year, 1983 - 1984
Keck School of Medicine of the University of Southern CaliforniaClass of 1983
Certifications & Licensure
CA State Medical License 1985 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 1100 citationsMethyLight: a high-throughput assay to measure DNA methylationCindy A. Eads, Kathleen D. Danenberg, Kazuyuki Kawakami, Leonard B. Saltz, Corey Blake
Nucleic Acids Research. 2000-04-15 - 2096 citationsUbiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisYurij Ionov, Miguel A. Peinado, Sergei Malkhosyan, Darryl Shibata, Manuel Perucho
Nature. 1993-06-10 - 24 citationsMany private mutations originate from the first few divisions of a human colorectal adenomaHaeyoun Kang, Matthew P. Salomon, Andrea Sottoriva, Junsong Zhao, Morgan Toy
The Journal of Pathology. 2015-08-03
Press Mentions
Lawrence J. Ellison Institute for Transformative Medicine of USC Explores Breakthrough Tissue "Fingerprints" Concept for Cancer Diagnostics Using Oracle Cloud TechnologyJuly 9th, 2020
Deadly Cancers Show Early, Detectable Differences from Benign TumoursMay 15th, 2018
Deadly Cancers Show Early, Detectable Differences from Benign TumorsMay 14th, 2018- Join now to see all
Grant Support
- Tumor Diversity As A Biomarker For Colorectal CancerNational Cancer Institute2010–2011
- A Cancer Evolution Space-Time MachineNational Cancer Institute2010–2011
- How DO Colorectal Cancers Arise Despite Surveillance?National Cancer Institute2005–2007
- Mouse Models Of Early Intestinal NeoplasiaNational Cancer Institute1999–2007
- Human Colon Stem Cell And Crypt DynamicsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
- Fixing Fixed DNANational Cancer Institute2001–2002
- Pathology Of Tumor GrowthNational Cancer Institute1997–1999
- Pathology Of Gastric CancerNational Cancer Institute1993–1997
- Pathology Of Tumor GrowthNational Cancer Institute1996
